市场调查报告书
商品编码
1450991
2024-2032 年等温核酸扩增技术市场报告(按产品、技术、应用、最终用户和地区划分)Isothermal Nucleic Acid Amplification Technology Market Report by Product, Technology, Application, End-User, and Region 2024-2032 |
2023年,全球等温核酸扩增技术(INAAT)市场规模达到31亿美元。展望未来, IMARC Group预计到2032年市场规模将达到79亿美元,2024年复合年增长率(CAGR)为 10.8%。2032 .
等温核酸扩增技术 (INAAT) 用于分子生物学和重组 DNA 技术中,用于检测和鑑定核酸。它通常用于在恆温下扩增核酸,从而无需热循环仪设备。主要用于RNA、DNA、细胞、蛋白质、小分子和离子,以确保遗传性疾病、遗传性疾病和传染病的快速、敏感和准确的诊断。它产生的扩增子用于生产多功能核酸奈米材料。除此之外,它还有助于检测各种传染病,例如(HIV)、结核病、流感、甲型和乙型肝炎、衣原体和淋病(CT/NG)。因此,INAAT 在全球范围内获得了巨大的关注。
用于检测冠状病毒病(COVID-19)的 INAAT 的持续开发是积极影响市场的关键因素之一。与此一致的是,全球老年人口的增加、癌症和其他慢性疾病盛行率的上升,以及对有效诊断和治疗替代方案的需求不断增加,正在促进市场成长。除此之外,采用环介导等温扩增 (LAMP) 测试来扩增 DNA 和 RNA 以及基因改造生物 (GMO) 的鑑定正在催化对 INAAT 的需求。此外,链置换扩增(SDA)、单引子等温扩增(SPIA)和重组酶聚合酶扩增(RPA)的发展是另一个生长诱导因子。此外,领先市场参与者增加对研发(R&D)活动的投资预计将推动市场发展。
The global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. It is majorly utilized for RNA, DNA, cells, proteins, small molecules, and ions to ensure the rapid, sensitive and accurate diagnosis of genetic, inherited, and infectious diseases. It generates amplicons that are employed in producing versatile nucleic acid nanomaterials. Besides this, it assists in detecting various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia, and gonorrhea (CT/NG). As a result, INAAT is gaining immense traction across the globe.
The ongoing development in INAAT for detecting coronavirus disease (COVID-19) represents one of the key factors positively influencing the market. In line with this, the increasing geriatric population globally and the rising prevalence of cancer and other chronic medical disorders, along with the escalating demand for efficient diagnosis and treatment alternatives, are contributing to the market growth. Apart from this, the adoption of loop-mediated isothermal amplification (LAMP) tests to amplify DNA and RNA and the identification of genetically modified organisms (GMOs) is catalyzing the demand for INAAT. Furthermore, the development of strand displacement amplification (SDA), single primer isothermal amplification (SPIA), and recombinase polymerase amplification (RPA) are acting as another growth-inducing factor. Moreover, increasing investments in research and development (R&D) activities by leading market players are projected to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global isothermal nucleic acid amplification technology market report, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, technology, application, and end-user.
Instruments
Reagents
Reagents hold the majority of the global isothermal nucleic acid amplification technology market share due to their increasing use in therapeutics.
Helicase-Dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-Mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-Based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
TMA accounts for the majority of the total market share as it allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps and less processing time.
Infectious Disease Diagnosis
Hepatitis
CT/NG
HIV
Influenza
Others
Blood Screening
Others
Infectious disease diagnosis currently dominates the market due to the rising prevalence of infectious diseases across the globe.
Hospitals
Diagnostic Laboratories
Research Laboratories
Others
Hospitals presently dominate the market due to the increasing number of hospitals and significant development in the healthcare industry.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market due to the shifting consumer preference for INAAT testing over traditional diagnostic procedures.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Abbott Laboratories, bioMerieux SA, Becton, Dickinson and Company, Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, and Ustar Biotechnologies Ltd.